Experiments for taxon Oryza sativa (POACEAE)

Experiments (494 results)

494 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
86682	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	ERYTHRONO-1-4-LACTONE,D: 2-C-HYDROXY-METHYL:
482857	IDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	SITOSTEROL,BETA: FERULATEORYZANOL,GAMMA:STIGMASTEROL FERULATECYCLOARTANOL FERULATECYCLOARTENOL FERULATECYCLOARTANOL,24-METHYLENE: FERULATECAMPESTEROL FERULATE
550800	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)
716939	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
454170	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
728373	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)	O
991475	PLANT TISSUE CULTURE MARKER CODEIDENTIFICATION OF		Oryza sativa (POACEAE)
545102	EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTILEUCORRHEA ACTIVITY	Oryza sativa (POACEAE)
716948	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	VANILLIC ACID
1114953	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ESTROGENIC EFFECT	Oryza sativa (POACEAE)
1166404	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
69964	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	ORYZA SATIVA POLYSACCHARIDE RBS
1267954	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPERLIPIDEMIC ACTIVITY	Oryza sativa (POACEAE)
716949	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
716973	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	TRICIN
634237	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	AUXIN-BINDING PROTEIN
66424	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PROTEIN(ORYZA SATIVA)
262078	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREHPLC SEPARATION DATA FORCD SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOTRIENOL,DEMETHYL:
716933	PHARMACOLOGY OF COMPOUND - IN VITRO	COLONY FORMATION INHIBITION	Oryza sativa (POACEAE)	CAFFEIC ACID
716927	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CAFFEIC ACID
50903	IDENTIFICATION IN BY GLC		Oryza sativa (POACEAE)	ABSCISIC ACID
316564	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
826219	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIN
716962	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	FERULIC ACID
319216	PLANT TISSUE CULTURE MARKER CODEPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSEFFECTS ON PLANT GROWTH MARKER CODE	KININ-LIKE ACTIVITY	Oryza sativa (POACEAE)	KINETIN
262083	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,DEMETHYL:
854393	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	VANILLIC ACIDBENZOIC ACID,4-HYDROXY:FERULIC ACIDCOUMARIC ACID,PARA:
4095	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ABORTIFACIENT EFFECT	Oryza sativa (POACEAE)
86677	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ERYTHRONO-1-4-LACTONE,D:
1114143	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ABORTIFACIENT EFFECT	Oryza sativa (POACEAE)
474898	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOPHEROL,ALPHA:
683989	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ABORTIFACIENT EFFECT	Oryza sativa (POACEAE)
481175	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	RICE BRAN SACCHARIDE
361349	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	RESORCINOL,5-(HEPTADEC-12-ENYL):
316558	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Oryza sativa (POACEAE)
27264	IDENTIFICATION IN BY GLCCHEMOTAXONOMY MARKER CODE		Oryza sativa (POACEAE)	CYLINDRINARUNDOINARBORINOL,ISO:AMYRIN,BETA:
827889	PHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)
750101	PCR ANALYSIS(PLANT)		Oryza sativa (POACEAE)
625340	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)	SITOSTEROL,BETA: FERULATE
86687	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ARABINONO-1-4-LACTONE,D:
43041	IDENTIFICATION IN BY GLC		Oryza sativa (POACEAE)	FRIEDELINCYLINDRINARUNDOINARBORINOL,ISO:CAMPESTEROLSTIGMASTEROLSITOSTEROL,BETA:MILIACINAMYRIN,BETA:
651409	PHARMACOLOGY OF EXTRACT - IN VIVO	DIABETES-INHIBITION OF DEVELOPMENT	Oryza sativa (POACEAE)
716951	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
520721	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Oryza sativa (POACEAE)	ORYZACYSTATIN II
997494	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)	PROTEIN
716920	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
539049	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISECRETORY EFFECT	Oryza sativa (POACEAE)
512408	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	SALICYLIC ACID
348157	PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Oryza sativa (POACEAE)	PHYTOCASSANE E
855562	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZARAN A
413560	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
1264292	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYANIDIN DIGLYCOSIDE
584122	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
480504	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)	ACONITIC ACID
482695	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYANIDIN 3-O-BETA-D-GLUCOSIDE
572423	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
785987	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Oryza sativa (POACEAE)
761780	PCR ANALYSIS(PLANT)		Oryza sativa (POACEAE)
899187	PHARMACOLOGY OF EXTRACT - IN VIVO	ULCEROGENIC ACTIVITY	Oryza sativa (POACEAE)
173240	PHARMACOLOGY OF COMPOUND - IN VITRO	PHAGOCYTOSIS STIMULATION	Oryza sativa (POACEAE)	ORYZATENSIN
507026	MEDICINAL FOLKLORE REPORTED FOR	ANTIPARASITIC ACTIVITY	Oryza sativa (POACEAE)
716950	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
716919	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
716941	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
839399	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY(PLANT PATHOGENS)	Oryza sativa (POACEAE)
1047294	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
489018	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIULCER ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
132709	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	MOMILACTONE ASAKURANETINORYZALEXIN D
18496	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTENSIVE ACTIVITY	Oryza sativa (POACEAE)
492247	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
716955	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
572111	PHARMACOLOGY OF EXTRACT - IN HUMANS	SLEEP(SPONTANEOUS) POTENTIATION	Oryza sativa (POACEAE)
975639	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIC ACID
983861	IDENTIFICATION OF		Oryza sativa (POACEAE)	ACONITIC ACID,TRANS:
52369	UV SPECTRUM GIVEN FORIDENTIFICATION IN BY PAPER CHROMATOGRAPHYPAPER CHROMATOGRAPHY DATA REPORTEDCHEMOTAXONOMY MARKER CODE		Oryza sativa (POACEAE)	TRICIN-5-O-BETA-D-GLUCOSIDE
716924	PHARMACOLOGY OF COMPOUND - IN VITRO	COLONY FORMATION INHIBITION	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
1324496	MEDICINAL FOLKLORE REPORTED FOR	ANALGESIC ACTIVITY	Oryza sativa (POACEAE)
716952	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
713035	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	ORYZANOL
648453	PHARMACOLOGY OF EXTRACT - IN VITRO	CELL PROLIFERATION INHIBITION	Oryza sativa (POACEAE)
1205706	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)
507024	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
441724	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	DIAZEPAM,N-DEMETHYL:
1000306	PHARMACOLOGY OF EXTRACT - IN VITRO	NADH REDUCTASE INHIBITION	Oryza sativa (POACEAE)
544692	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	LABOR INDUCTION EFFECT	Oryza sativa (POACEAE)
474895	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOPHEROL,DELTA:
442082	PHARMACOLOGY OF EXTRACT - IN VIVO	LYMPHOCYTE STIMULATION	Oryza sativa (POACEAE)
625339	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	SITOSTEROL,BETA: FERULATE
1189234	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)
155526	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Oryza sativa (POACEAE)	RICE ANTIFUNGAL PROTEIN I
897576	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
625334	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULATE
489011	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
716974	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	TRICIN
173239	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZATENSIN
999778	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	SITOSTEROL,BETA: CELLOTETRAOSIDESITOSTEROL,BETA: CELLOPENTAOSIDE
716944	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	VANILLIC ACID
716959	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	FERULIC ACID
1210881	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
716913	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)
474892	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOTRIENOL,BETA:
716928	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CAFFEIC ACID
262086	PHARMACOLOGY OF COMPOUND - IN VITRO	HMG-CO-A REDUCTASE INHIBITION	Oryza sativa (POACEAE)	TOCOTRIENOL,ALPHA:
24345	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ESTROGENIC EFFECT	Oryza sativa (POACEAE)
716938	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
331960	ISOLATION OF COMPOUND WITH UNKNOWN STRUCTURE		Oryza sativa (POACEAE)	WAX(ORYZA SATIVA)
716966	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	SINAPIC ACID
716937	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
489014	PHARMACOLOGY OF COMPOUND - IN VIVO	CNS DEPRESSANT ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
716977	PHARMACOLOGY OF COMPOUND - IN VITRO	COLONY FORMATION INHIBITION	Oryza sativa (POACEAE)	TRICIN
855568	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZARAN C
1198483	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Oryza sativa (POACEAE)
914207	PHARMACOLOGY OF EXTRACT - IN VIVO	LIPID METABOLISM EFFECTS	Oryza sativa (POACEAE)
483415	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Oryza sativa (POACEAE)
196638	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Oryza sativa (POACEAE)	PHYTOCASSANE E
716963	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	SINAPIC ACID
942936	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)
66336	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
762528	QUANTITATIVE DATA REPORTEDIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	DIAZEPAMDIAZEPAM,DEMETHYL:
881506	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	POLYSACCHARIDE RON
855563	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZARAN A
563575	MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)
1187117	PHARMACOLOGY OF EXTRACT - IN VITRO	MUTAGENIC ACTIVITY	Oryza sativa (POACEAE)
914208	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
599457	PHARMACOLOGY OF EXTRACT - IN VIVO	SALIVARY SECRETION INCREASE	Oryza sativa (POACEAE)
728374	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
1001571	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
924434	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	HYPOTRIGLYCERIDEMIA ACTIVITY	Oryza sativa (POACEAE)
785984	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
1189240	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZABRAN C
716958	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	FERULIC ACID
296990	AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	TRANSFER PROTEIN 2
441723	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	DIAZEPAM
1267955	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPERCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
1153922	EFFECTS DUE TO A COMBINATION OF DRUGSANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	FEMALE DISORDERS(UNSPECIFIED)	Oryza sativa (POACEAE)
1189238	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZABRAN B
110580	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)	ORYZALIDE A
1185390	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
489589	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZANOL
843483	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	ALANINE,BETA-(5-METHYL-ISOXAZOLIN-3-ON-2-YL):
716947	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	VANILLIC ACID
879696	IDENTIFICATION OF		Oryza sativa (POACEAE)	ALANINE,D: D-ALANYL:ALANYL-GLYCINE,D:
86685	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	LYXONO-1-4-LACTONE,D: 2-DEOXY:
509857	IDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	PHYTIC ACID
470717	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
1189236	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZABRAN A
982933	AGRONOMIC STUDIES REPORTED		Oryza sativa (POACEAE)
683988	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ANTIIMPLANTATION EFFECT	Oryza sativa (POACEAE)
354044	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	CHRYSANTHEMINPAEONIDIN-3-O-BETA-D-GLUCOSIDE
348348	CMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	CHOLESTEROL
316563	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
716932	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CAFFEIC ACID
86692	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	RHAMNONO-1-4-LACTONE,L:
643564	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
545101	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
572422	MEDICINAL FOLKLORE REPORTED FOR	ANTITUSSIVE ACTIVITY	Oryza sativa (POACEAE)
489012	PHARMACOLOGY OF COMPOUND - IN VIVO	BARBITURATE SLEEPING TIME DECREASED	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
924430	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	INSULIN RELEASE INHIBITION	Oryza sativa (POACEAE)
566630	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
425561	TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS	URTICARIANT ACTIVITY	Oryza sativa (POACEAE)
566632	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)
173241	PHARMACOLOGY OF COMPOUND - IN VITRO	SUPEROXIDE STIMULATION	Oryza sativa (POACEAE)	ORYZATENSIN
934849	QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	PYRROLINE,1: 2-ACETYL:
520716	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZACYSTATIN I
458661	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)	PROLAMINE
262079	PHARMACOLOGY OF COMPOUND - IN VITRO	HMG-CO-A REDUCTASE INHIBITION	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOTRIENOL,DEMETHYL:
262091	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDROGEN PEROXIDE SCAVENGER ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,DELTA:
262090	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,GAMMA:
755094	PHARMACOLOGY OF EXTRACT - IN VIVO	LIPASE(PANCREATIC) INHIBITION	Oryza sativa (POACEAE)
785988	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Oryza sativa (POACEAE)
948744	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)
1205707	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
899188	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIULCER ACTIVITY	Oryza sativa (POACEAE)
586580	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIACNE ACTIVITY	Oryza sativa (POACEAE)
389740	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZANOL,GAMMA:
334179	QUANTITATIVE DATA REPORTEDTOXICITY MARKER CODEIDENTIFICATION OF SUBSTANCES NOT EXPECTED		Oryza sativa (POACEAE)	COUMARINCOUMARIC ACID,ORTHO:PIRICULARINTENUAZONIC ACID
520720	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZACYSTATIN II
855570	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZARAN D
316560	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
86681	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ERYTHRONO-1-4-LACTONE,D: 2-C-HYDROXY-METHYL:
481176	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARCINOGENESIS INHIBITION	Oryza sativa (POACEAE)
586579	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	REDUCTASE,5-ALPHA: INHIBITION	Oryza sativa (POACEAE)
316559	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
803795	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	BENZOIC ACID,4-HYDROXY:
442079	PHARMACOLOGY OF EXTRACT - IN VIVO	WBC STIMULANT	Oryza sativa (POACEAE)
625284	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	DAUCOSTEROL
319215	PLANT TISSUE CULTURE MARKER CODEPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSEFFECTS ON PLANT GROWTH MARKER CODE	AUXIN-LIKE ACTIVITY	Oryza sativa (POACEAE)	NAPHTHALENE-1-ACETIC ACIDAUXIN
941287	PHARMACOLOGY OF COMPOUND - IN VIVO	PLATELET AGGREGATION INHIBITION	Oryza sativa (POACEAE)	ORYZANOL
803796	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)	BENZOIC ACID,4-HYDROXY:CINNAMIC ACID,TRANS: 4-HYDROXY:
1274141	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYCLOARTENOL FERULATE
762253	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ESTROGENIC EFFECT	Oryza sativa (POACEAE)
892917	PLANT TISSUE CULTURE MARKER CODEISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	RHAMNOGALACTURONAN I
110579	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZALIDE A
714611	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	POLYSACCHARIDE RBS
563574	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
716912	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)
948743	PHARMACOLOGY OF EXTRACT - IN VITRO	INTERLEUKIN INDUCTION	Oryza sativa (POACEAE)
520719	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Oryza sativa (POACEAE)	ORYZACYSTATIN I
1232164	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANS	CARCINOGENESIS INHIBITION	Oryza sativa (POACEAE)
716923	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
716969	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	SINAPIC ACID
716940	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
489015	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
803797	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)	BENZOIC ACID,4-HYDROXY:CINNAMIC ACID,TRANS: 4-HYDROXY:
262080	PHARMACOLOGY OF COMPOUND - IN VITRO	FATTY ACID SYNTHASE INHIBITION	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOTRIENOL,ALPHA:TOCOTRIENOL,DEMETHYL:
564025	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZACYSTATIN
584123	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
642453	PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	SITOSTEROL,BETA:
86688	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	ARABINONO-1-4-LACTONE,D:
996879	QUANTITATIVE DATAISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Oryza sativa (POACEAE)	PHYTIN
18497	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)	Oryza sativa (POACEAE)
442080	PHARMACOLOGY OF EXTRACT - IN VIVO	LYMPHOCYTE STIMULATION	Oryza sativa (POACEAE)
716929	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CAFFEIC ACID
86676	PHARMACOLOGY - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)
507027	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIGIARDIASIS ACTIVITY	Oryza sativa (POACEAE)
728375	MEDICINAL FOLKLORE REPORTED FOR	WOUND HEALING ACCELERATION	Oryza sativa (POACEAE)
66395	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZA SATIVA LECTIN
681496	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIATHEROSCLEROTIC ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOPHEROL,ALPHA:
1062500	PHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
881507	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	POLYSACCHARIDE RON
536416	IDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	KAUR-16-ENE,ENT:SQUALENEKAUR-15-ENE,ENT:
295120	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ACHILLEOL A
839398	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY(PLANT PATHOGENS)	Oryza sativa (POACEAE)
625338	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	BRASSICASTEROL,22-DIHYDRO: FERULATE
166136	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZA ANTIFUNGAL PROTEIN RAFPI
1145415	PHARMACOLOGY OF COMPOUND - IN VITRO	FEEDING DETERRENT(INSECT)	Oryza sativa (POACEAE)	CAMPESTEROLSTIGMASTEROLSITOSTEROL,BETA:
955658	PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBED	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
132708	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Oryza sativa (POACEAE)	ORYZALEXIN S
251955	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	PANTOYLLACTONE PRIMEVEROSIDE
648452	PHARMACOLOGY OF EXTRACT - IN VITRO	APOPTOSIS INDUCTION	Oryza sativa (POACEAE)
483414	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Oryza sativa (POACEAE)
716954	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
615290	X-RAY CHRYSTALLOGRAPHIC STUDIESISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPHARMACOLOGY OF COMPOUND - EFFECT ON PLANTSEFFECTS ON PLANT GROWTH MARKER CODE	PLANT GROWTH INHIBITOR(UNSPEC)	Oryza sativa (POACEAE)	MOMILACTONE C
333911	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
262087	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDROGEN PEROXIDE SCAVENGER ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,ALPHA:
731717	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTRIGLYCERIDEMIA ACTIVITY	Oryza sativa (POACEAE)
716916	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)
716965	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	SINAPIC ACID
562161	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
262089	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDROGEN PEROXIDE SCAVENGER ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,GAMMA:
969407	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	KAUR-16-ENE,ENT:SANDARACOPIMARA-8(14)-15-DIENE,ENT:PIMARA-7-15-DIENE,9-BETA: (H):
855567	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZARAN C
413553	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
1153921	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	FEMALE DISORDERS(UNSPECIFIED)	Oryza sativa (POACEAE)
716943	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	VANILLIC ACID
1030935	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
86684	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	LYXONO-1-4-LACTONE,D:
731723	PHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOTRIGLYCERIDEMIA ACTIVITY	Oryza sativa (POACEAE)
1006979	PMR SPECTRUM REPORTEDTLC DATA REPORTEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	MOMILACTONE AMOMILACTONE B
474893	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOTRIENOL,GAMMA:
994357	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	POLYMERASE,DNA:
714663	PCR ANALYSIS(PLANT)		Oryza sativa (POACEAE)
1232702	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ESTROGENIC EFFECT	Oryza sativa (POACEAE)
474894	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOTRIENOL,ALPHA:
716936	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
716976	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	TRICIN
625333	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULATE
1198481	MEDICINAL FOLKLORE REPORTED FOR	LIVER EFFECTS(UNSPECIFIED)	Oryza sativa (POACEAE)
522182	BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	CASTASTERONE,3-EPI:
716922	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
716968	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	SINAPIC ACID
512310	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)	GLUTATHIONE
590944	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
86691	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	RHAMNONO-1-4-LACTONE,L:
881505	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	POLYSACCHARIDE RON
868989	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	GLUCAN,ALPHA:
483413	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Oryza sativa (POACEAE)
1052512	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
1267398	IDENTIFICATION OF		Oryza sativa (POACEAE)	SQUALENE
1189237	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)	ORYZABRAN A
614911	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION AFTER CHEMICAL TREATMENT		Oryza sativa (POACEAE)	CYCLOEUCALENOL
566631	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Oryza sativa (POACEAE)
1189239	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZABRAN B
1188197	MEDICINAL FOLKLORE REPORTED FOR	LIVER EFFECTS(UNSPECIFIED)	Oryza sativa (POACEAE)
86680	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	ERYTHRONO-1-4-LACTONE,D: 2-C-METHYL:
505995	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
964454	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	DNA TOPOISOMERASE I
643565	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIANAPHYLACTIC ACTIVITY	Oryza sativa (POACEAE)
489009	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPOTHERMIC ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
295121	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	GRAMINOL A
451460	PHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)
1001570	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
544691	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
1183409	PHARMACOLOGY OF EXTRACT - IN VIVO	INTERFERON INDUCTION STIMULATION	Oryza sativa (POACEAE)
437989	BIOSYNTHESISISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	SAKURANETIN
750380	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIC ACID
489019	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIAMNESIC ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
714610	CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	POLYSACCHARIDE RBS
716971	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	TRICIN
648433	SYNTHESIS OF ANALOGSWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	FERULIC ACID
716911	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
731721	PHARMACOLOGY OF EXTRACT - IN VIVO	SERUM HDL ELEVATING EFFECT	Oryza sativa (POACEAE)
755096	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTRIGLYCERIDEMIA ACTIVITY	Oryza sativa (POACEAE)
716931	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CAFFEIC ACID
262081	PHARMACOLOGY OF COMPOUND - IN VITRO	CHOLESTEROL-7-ALPHA-HYDROXYLASE INHIBITION	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOTRIENOL,ALPHA:TOCOTRIENOL,DEMETHYL:
1120854	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FORANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Oryza sativa (POACEAE)
1205708	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
86686	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	LYXONO-1-4-LACTONE,D: 2-DEOXY:
86679	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ERYTHRONO-1-4-LACTONE,D: 2-C-METHYL:
1264565	MEDICINAL FOLKLORE REPORTED FOR	APPETITE STIMULANT	Oryza sativa (POACEAE)
1189241	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZABRAN C
470716	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
924431	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	GLUCAGON INDUCTION	Oryza sativa (POACEAE)
158939	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	SATIOMEM
803798	CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CINNAMIC ACID,TRANS: 4-HYDROXY:
625331	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
262092	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDROGEN PEROXIDE SCAVENGER ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:
483416	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Oryza sativa (POACEAE)
368239	PLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	SITOSTEROL,BETA:
818773	PHARMACOLOGY OF EXTRACT - IN VIVO	LIPID METABOLISM EFFECTS	Oryza sativa (POACEAE)
941286	PHARMACOLOGY OF COMPOUND - IN VIVO	PLATELET AGGREGATION INHIBITION	Oryza sativa (POACEAE)	ORYZANOL
716946	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	VANILLIC ACID
572112	PHARMACOLOGY OF EXTRACT - IN HUMANS	PARATHYROID HORMONE INDUCTION	Oryza sativa (POACEAE)
599458	PHARMACOLOGY OF EXTRACT - IN VIVO	PROTEIN SECRETION STIMULATION	Oryza sativa (POACEAE)
489017	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPOTENSIVE ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
716957	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	FERULIC ACID
520718	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)	ORYZACYSTATIN I
778115	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTISTRESS ACTIVITY	Oryza sativa (POACEAE)
489016	PHARMACOLOGY OF COMPOUND - IN VIVO	SPONTANEOUS ACTIVITY REDUCTION	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
1151207	TOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANS	DERMATITIS PRODUCING EFFECT	Oryza sativa (POACEAE)
716935	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	COUMARIC ACID,PARA:
23253	ANTIFERTILITYMEDICINAL FOLKLORE REPORTED FOR	ABORTIFACIENT EFFECT	Oryza sativa (POACEAE)
1062498	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
331061	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)	ALUMINUM
716975	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	TRICIN
716970	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	TRICIN
778116	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIFATIGUE ACTIVITY	Oryza sativa (POACEAE)
941285	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZANOL
731722	PHARMACOLOGY OF EXTRACT - IN HUMANS	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
431923	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	RICE POLYSACCHARIDE
643566	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIANAPHYLACTIC ACTIVITY	Oryza sativa (POACEAE)
442081	PHARMACOLOGY OF EXTRACT - IN VIVO	WBC STIMULANT	Oryza sativa (POACEAE)
536602	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
1007966	IDENTIFICATION IN BY TLC		Oryza sativa (POACEAE)	LYSINEMETHIONINELEUCINETYROSINELEUCINE,ISO:ASPARTIC ACIDGLUTAMIC ACIDSERINEGLYCINETHREONINEVALINE
393586	IDENTIFICATION OF		Oryza sativa (POACEAE)	OLEIN,MONO:CASTASTERONETEASTERONECASTASTERONE,6-DEOXY:PALMITIN,MONO:
1183665	PHARMACOLOGY OF EXTRACT - IN VIVOPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)
731716	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
474897	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOPHEROL,GAMMA:
564026	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTEINASE INHIBITION	Oryza sativa (POACEAE)	ORYZACYSTATIN
1145414	IDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	CAMPESTEROLSTIGMASTEROLSITOSTEROL,BETA:
958554	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
609135	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
1014688	PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	ORYZA SATIVA SUBSTANCE RBF-PMORYZA SATIVA SUBSTANCE RBF-X
716942	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	VANILLIC ACID
1014754	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODEELECTROPHORESIS USED	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)
1074162	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
489008	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
586581	PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS	HAIR STIMULANT EFFECT	Oryza sativa (POACEAE)
474890	HPLC DATA REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	SITOSTEROL,BETA: FERULATECYCLOARTANOL FERULATECYCLOARTENOL FERULATECYCLOARTANOL,24-METHYLENE: FERULATECAMPESTEROL FERULATE
716915	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)
716953	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CINNAMIC ACID,METHOXY:
262084	PHARMACOLOGY OF COMPOUND - IN VIVO	CHOLESTEROL LEVEL DECREASE	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOTRIENOL,ALPHA:TOCOTRIENOL,DEMETHYL:TOCOTRIENOL,DELTA:TOCOTRIENOL,GAMMA:
348155	PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTOCASSANE APHYTOCASSANE BPHYTOCASSANE DPHYTOCASSANE C
716926	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	CAFFEIC ACID
716964	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	SINAPIC ACID
855566	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZARAN B
319214	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
562162	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Oryza sativa (POACEAE)
361350	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	RESORICINOL,5-TRIDECYL:RESORCINOL,5-HEPTADECYL:RESORCINOL,5-PENTADECYL:
555048	AMINO ACID ANALYSIS OFQUANTITATIVE DATAPATENT DESCRIBEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZA PROTEIN PHI
572421	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
881508	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	POLYSACCHARIDE RON
196636	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDPLANT TISSUE CULTURE MARKER CODECMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	PHYTOCASSANE E
948742	PHARMACOLOGY OF EXTRACT - IN VITRO	WBC-MACROPHAGE STIMULANT	Oryza sativa (POACEAE)
69963	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ORYZA SATIVA POLYSACCHARIDE RBS
1004832	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
276405	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	QUINOL-2-ONE,4-CARBOMETHOXY-6-HYDROXY:
716917	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)
854527	PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIN
262088	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,ALPHA:
545100	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
625337	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CAMPESTEROL FERULATE
132707	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZALEXIN S
584851	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIC ACIDORYZENIN
618632	PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	PYRIDOXINE,5'-O-(BETA-D-GLUCOPYRANOSYL):
86689	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ARABINO-HEXONO-1-4-LACTONE,D: 3-DEOXY:
1004831	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
731724	PHARMACOLOGY OF EXTRACT - IN HUMANS	SERUM HDL ELEVATING EFFECT	Oryza sativa (POACEAE)
18494	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Oryza sativa (POACEAE)
625332	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYCLOARTENOL FERULATE
841671	MASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORTLC DATA REPORTEDIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	ORYZA SATIVA PHYTOGLYCOLIPID
1043690	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	NICOTIANAMINE
731718	PHARMACOLOGY OF EXTRACT - IN VIVO	SERUM HDL ELEVATING EFFECT	Oryza sativa (POACEAE)
1052513	ORGAN CULTURE IN VITRO OF		Oryza sativa (POACEAE)
785986	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Oryza sativa (POACEAE)
899186	PHARMACOLOGY OF EXTRACT - IN VIVO	ULCEROGENIC ACTIVITY	Oryza sativa (POACEAE)
86678	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	ERYTHRONO-1-4-LACTONE,D:
568345	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
716921	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
520722	PHARMACOLOGY OF COMPOUND - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Oryza sativa (POACEAE)	ORYZACYSTATIN II
166137	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Oryza sativa (POACEAE)	ORYZA ANTIFUNGAL PROTEIN RAFPI
86683	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	LYXONO-1-4-LACTONE,D:
716961	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	FERULIC ACID
316562	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
625336	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTANOL,24-METHYLENE: FERULATE
316565	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
1035280	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FORTLC DATA REPORTED		Oryza sativa (POACEAE)	ORYZALEXIN A
716978	PHARMACOLOGY OF COMPOUND - IN VITRO	COLONY FORMATION INHIBITION	Oryza sativa (POACEAE)	TRICIN
262082	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDROGEN PEROXIDE SCAVENGER ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,DEMETHYL:
1171900	PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARCINOGENESIS INHIBITION	Oryza sativa (POACEAE)
489010	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTICONVULSANT ACTIVITY	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
924432	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
69965	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	ORYZA SATIVA POLYSACCHARIDE RBS
489013	PHARMACOLOGY OF COMPOUND - IN VIVO	CNS EFFECTS(GENERAL)	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
478630	PLANT TISSUE CULTURE MARKER CODEWORK DESCRIBED MAINLY CONCERNS METHODOLOGY		Oryza sativa (POACEAE)
716972	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	TRICIN
1198482	PHARMACOLOGY OF EXTRACT - IN VITROVOUCHER SPECIMEN REPORTED FOR	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	Oryza sativa (POACEAE)
862374	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	TRICINVIOLANTHIN
716967	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	SINAPIC ACID
262093	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:
991474	PLANT TISSUE CULTURE MARKER CODEQUANTITATIVE DATAIDENTIFICATION OF		Oryza sativa (POACEAE)
716945	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	VANILLIC ACID
330345	BIOSYNTHESISISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	ASPARAGINE
1262837	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)
1245870	PHARMACOLOGY OF EXTRACT - IN VIVOANTIFERTILITY	ESTROGENIC EFFECT	Oryza sativa (POACEAE)
550799	VOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)
1120853	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Oryza sativa (POACEAE)	O
1264293	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYANIDIN MONOGLYCOSIDE
1151909	PHARMACOLOGY OF EXTRACT - IN VITROPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIMUTAGENIC ACTIVITY	Oryza sativa (POACEAE)
332717	GC DATA REPORTEDIDENTIFICATION OFQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)
1189242	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZABRAN D
716956	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	FERULIC ACID
490920	BIOSYNTHESISQUANTITATIVE DATA REPORTEDISOLATION FROM DURING BIOSYNTHESIS STUDY		Oryza sativa (POACEAE)	PUTRESCINE
681495	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	TOCOTRIENOL,DIDEMETHYL:TOCOPHEROL,ALPHA:
1189243	PHARMACOLOGY OF COMPOUND - IN VIVO	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	ORYZABRAN D
583829	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
965473	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIN
333771	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
431924	PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED	HYPOGLYCEMIC ACTIVITY	Oryza sativa (POACEAE)	RICE POLYSACCHARIDE
196637	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY(PLANT PATHOGENS)	Oryza sativa (POACEAE)	PHYTOCASSANE E
1205705	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Oryza sativa (POACEAE)
474891	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOTRIENOL,DELTA:
66396	PHARMACOLOGY OF COMPOUND - IN VITRO	AGGLUTININ ACTIVITY	Oryza sativa (POACEAE)	ORYZA SATIVA LECTIN
1054141	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZALEXIN CORYZALEXIN B
899189	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIULCER ACTIVITY	Oryza sativa (POACEAE)
716960	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	FERULIC ACID
965281	MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY GC/MS		Oryza sativa (POACEAE)	PYRROLIDINE,1: 2-ACETYL:
938630	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)
507025	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
320751	IDENTIFICATION OFQUANTITATIVE DATA REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDCHEMOTAXONOMY MARKER CODE		Oryza sativa (POACEAE)	SHIKIMIC ACIDQUINIC ACID
474896	HPLC DATA REPORTEDIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	TOCOPHEROL,BETA:
538926	BIOSYNTHESISIDENTIFICATION IN BY HPLCQUANTITATIVE DATA		Oryza sativa (POACEAE)	SALICYLIC ACID
583830	MEDICINAL FOLKLORE REPORTED FOR	SKIN IMPROVEMENT EFFECT	Oryza sativa (POACEAE)
716930	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	CAFFEIC ACID
155525	AMINO ACID ANALYSIS OFISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	RICE ANTIFUNGAL PROTEIN I
1048594	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIULCER ACTIVITY	Oryza sativa (POACEAE)
625335	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYCLOARTANOL,24-METHYLENE: FERULATE
1007965	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OFMEDICINAL FOLKLORE REPORTED FOR	ANTIHEPATOTOXIC ACTIVITY	Oryza sativa (POACEAE)	TRICIN
1187116	PHARMACOLOGY OF EXTRACT - IN VITRO	MUTAGENIC ACTIVITY	Oryza sativa (POACEAE)
519843	IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED		Oryza sativa (POACEAE)	CYCLOARTENOL FERULATECYCLOARTANOL,24-METHYLENE: FERULATECAMPESTEROL FERULATE
716914	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)
572110	PHARMACOLOGY OF EXTRACT - IN HUMANS	BONE RESORPTION STIMULATION	Oryza sativa (POACEAE)
333348	GC DATA REPORTEDCARCINOGENIC DATA (MARKER CODE)QUANTITATIVE DATA REPORTEDTOXICITY MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)IDENTIFICATION OF SUBSTANCES NOT EXPECTED		Oryza sativa (POACEAE)	PENICILLIC ACIDPATULIN
520717	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIVIRAL ACTIVITY	Oryza sativa (POACEAE)	ORYZACYSTATIN I
755095	PHARMACOLOGY OF EXTRACT - IN VIVO	CHOLESTEROL LEVEL DECREASE	Oryza sativa (POACEAE)
716918	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIPROLIFERATION ACTIVITY	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
731720	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOTRIGLYCERIDEMIA ACTIVITY	Oryza sativa (POACEAE)
996383	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
481376	IDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	CAFFEIC ACIDVANILLIC ACIDBENZOIC ACID,4-HYDROXY:PROTOCATECHUIC ACIDFERULIC ACIDCOUMARIC ACID,PARA:
18498	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Oryza sativa (POACEAE)
855569	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZARAN D
1062499	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
1189235	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	ORYZABRAN A
452196	IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTIC ACID
20876	ISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	CYANIDIN-5-GLYCOSIDE
897577	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTIHYPERLIPEMIC ACTIVITY	Oryza sativa (POACEAE)
316561	MEDICINAL FOLKLORE REPORTED FOR	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
703333	PHARMACOLOGY OF EXTRACT - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
526259	WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLC		Oryza sativa (POACEAE)	THIAMINE
18495	PHARMACOLOGY OF EXTRACT - IN VIVO	TOXICITY ASSESSMENT(QUANTITATIVE)	Oryza sativa (POACEAE)
643567	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIANAPHYLACTIC ACTIVITY	Oryza sativa (POACEAE)
881509	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Oryza sativa (POACEAE)	POLYSACCHARIDE RON
855564	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)	ORYZARAN A
64505	IDENTIFICATION IN BY PAPER CHROMATOGRAPHY		Oryza sativa (POACEAE)	VITEXINLUTEXINVITEXIN,ISO:LUTONARETIN
489020	PHARMACOLOGY OF COMPOUND - IN VIVO	GLUCOSE ABSORPTION INHIBITION	Oryza sativa (POACEAE)	CYCLOARTENOL FERULIC ACID ESTER
276406	PHARMACOLOGY OF COMPOUND - IN VITRO	RADICAL SCAVENGING EFFECT	Oryza sativa (POACEAE)	QUINOL-2-ONE,4-CARBOMETHOXY-6-HYDROXY:
785985	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE RADICAL SCAVENGING ACTIVITY	Oryza sativa (POACEAE)
86690	PHARMACOLOGY OF COMPOUND - EFFECT ON PLANTS	FUNGAL STIMULANT(PLANT PATHOGENS)	Oryza sativa (POACEAE)	ARABINO-HEXONO-1-4-LACTONE,D: 3-DEOXY:
716934	PHARMACOLOGY OF COMPOUND - IN VITRO	COLONY FORMATION INHIBITION	Oryza sativa (POACEAE)	CAFFEIC ACID
281286	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Oryza sativa (POACEAE)	STIGMASTANOL-TRANS-FERULATEGRAMISTEROL-TRANS-FERULATECITROSTADIENOL-CIS-FERULATECYCLOARTENOL-CIS-FERULATESITOSTEROL,BETA: CIS-FERULATECYCLOARTANOL,24-METHYLENE: CIS-FERULATECHOLESTEROL,24-METHYLENE: TRANS-FERULATECYCLOEUCALENOL-TRANS-FERULATECHOLESTEROL,24-METHYL: CIS-FERULATEGRAMISTEROL-CIS-FERULATESTIGMASTEROL-CIS-FERULATECHOLESTEROL,24-METHYLENE: CIS-FERULATECITROSTADIENOL-TRANS-FERULATESTIGMASTEROL-TRANS-FERULATESTIGMASTANOL-CIS-FERULATECYCLOEUCALENOL-CIS-FERULATE
348156	PLANT TISSUE CULTURE MARKER CODEPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF		Oryza sativa (POACEAE)	PHYTOCASSANE E
158340	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZALEXIN F
1151217	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSREVIEW OF	ANTIDIARRHEAL ACTIVITY	Oryza sativa (POACEAE)
924429	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY	Oryza sativa (POACEAE)
413554	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
262085	IDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR		Oryza sativa (POACEAE)	TOCOTRIENOL,ALPHA:TOCOTRIENOL,DELTA:TOCOTRIENOL,BETA:TOCOTRIENOL,GAMMA:
716925	PHARMACOLOGY OF COMPOUND - IN VITRO	COLONY FORMATION INHIBITION	Oryza sativa (POACEAE)	PROTOCATECHUIC ACID
731719	PHARMACOLOGY OF EXTRACT - IN VIVO	HYPOCHOLESTEROLEMIC ACTIVITY	Oryza sativa (POACEAE)
158940	PHARMACOLOGY OF COMPOUND - IN VIVO	ANOREXIC ACTIVITY	Oryza sativa (POACEAE)	SATIOMEM
855565	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Oryza sativa (POACEAE)	ORYZARAN B
1268123	PHARMACOLOGY OF EXTRACT - IN HUMANS	ANTITHYROID ACTIVITY	Oryza sativa (POACEAE)
924433	PHARMACOLOGY OF EXTRACT - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGS	HYPOLIPEMIC ACTIVITY	Oryza sativa (POACEAE)
413503	PLANT TISSUE CULTURE MARKER CODE		Oryza sativa (POACEAE)
613203	PLANT TISSUE CULTURE MARKER CODEREVIEW OF		Oryza sativa (POACEAE)

Experiments for taxon Oryza sativa (POACEAE)

Experiments (494 results)

Filters

Worktypes (55)

Pharmacology (106)

Compounds (197)

Organisms (227)